MDCO - The Medicines Company - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $8.83. This is a potential upside of $8.83 (0%) from yesterday's end of day stock price of $0.

The Medicines Company's activity chart (see below) currently has 52 price targets and 39 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.33% with an average time for these price targets to be met of 303 days.

Most recent stock forecast was given by JOEL BEATTY from BAIRD on 26-Nov-2019. First documented stock forecast 13-Feb-2014.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

4 years 11 months 22 days ago
(26-Nov-2019)

8/8 (100%)

$7.31 (15.33%)

148

Hold

$85

$0.1 (0.12%)

$85

4 years 11 months 22 days ago
(26-Nov-2019)

3/6 (50%)

$1.12 (1.34%)

950

Hold

$85

$0.1 (0.12%)

$100

4 years 11 months 23 days ago
(25-Nov-2019)

0/4 (0%)

$1.2 (1.43%)

Buy

$68

$-16.9 (-19.91%)

$68

4 years 11 months 23 days ago
(25-Nov-2019)

4/6 (66.67%)

$-15.8 (-18.85%)

235

Buy

$60

$-24.9 (-29.33%)

$55

5 years 17 days ago
(31-Oct-2019)

5/5 (100%)

$7.51 (14.31%)

205

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MDCO (The Medicines Company) average time for price targets to be met?

On average it took 303 days on average for the stock forecasts to be realized with a an average price target met ratio 83.33

Which analyst has the current highest performing score on MDCO (The Medicines Company) with a proven track record?

GBOLA AMUSA

Which analyst has the most public recommendations on MDCO (The Medicines Company)?

Gbola Amusa works at CHARDAN CAPITAL and has 5 price targets and 4 ratings on MDCO

Which analyst is the currently most bullish on MDCO (The Medicines Company)?

Madhu Kumar with highest potential upside - $0.1

Which analyst is the currently most reserved on MDCO (The Medicines Company)?

Jessica Fye with lowest potential downside - -$39.9

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?